Portal de Periódicos da CAPES

Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation

2011; Cold Spring Harbor Laboratory Press; Volume: 25; Issue: 23 Linguagem: Inglês

10.1101/gad.175950.111

1549-5477

Shannon E. Mullican, Christine A. Gaddis, Theresa Alenghat, Meera G. Nair, Paul Giacomin, Logan J. Everett, Dan Feng, David J. Steger, Jonathan Schug, David Artis, Mitchell A. Lazar,

Epigenetics and DNA Methylation

Macrophages, a key cellular component of inflammation, become functionally polarized in a signal- and context-specific manner. Th2 cytokines such as interleukin 4 (IL-4) polarize macrophages to a state of alternative activation that limits inflammation and promotes wound healing. Alternative activation is mediated by a transcriptional program that is influenced by epigenomic modifications, including histone acetylation. Here we report that macrophages lacking histone deacetylase 3 (HDAC3) display a polarization phenotype similar to IL-4-induced alternative activation and, furthermore, are hyperresponsive to IL-4 stimulation. Throughout the macrophage genome, HDAC3 deacetylates histone tails at regulatory regions, leading to repression of many IL-4-regulated genes characteristic of alternative activation. Following exposure to Schistosoma mansoni eggs, a model of Th2 cytokine-mediated disease that is limited by alternative activation, pulmonary inflammation was ameliorated in mice lacking HDAC3 in macrophages. Thus, HDAC3 functions in alternative activation as a brake whose release could be of benefit in the treatment of multiple inflammatory diseases.